Stem
cells are basic form of biological cells, which can differentiate
into other types of cells and can produce more of the same type of
stem cells. There are two types of stem cells, which include
embryonic stem cells, and adult stem cells. These cells are present
in areas in the body such as bone marrow, adipose tissue, and blood.
Stem cells are also taken from umbilical cord blood. The stem cell
population in the body is maintained through two processes, which
include obligatory asymmetric replication and stochastic
differentiation. Stem cells play an important role in the natural
healing process of the body and introduction of stem cells has shown
positive results in the treatment of many diseases such as cancer.
The significance of stem cell assays lies in the fact that they are
used for various processes such as viability or cytotoxicity
studying, isolation and purification of stem cells, cell
identification, cell proliferation, and cell differentiation for
research purposes. In the case of stem cell transplant, initially,
the embryonic stem cells are specialized into necessary adult cell
type. Then, these cells are used to replace the tissue that is
damaged due to any disease or injury. Commercially available stem
cell assays include NSC ICC Kit, Stem Cell Pluripotency Array, TaqMan
Array Mouse Stem Cell Pluripotency Panel, and TaqMan iPSC Sendai
Detection Kit.
Ask
Sample Copy of Research @
https://www.coherentmarketinsights.com/insight/request-sample/1632
Stem
Cell Assay Market Drivers
Rising
prevalence of various diseases such as cancer and cardiovascular
diseases, and potential of stem cell therapy in the management of
these diseases is expected to drive growth of the stem cell assay
market over the forecast period. According to the American Cancer
Society, in 2017, cancer was the second most common cause of death in
the U.S., which accounted for nearly 1 out of every 4 deaths. Novel
therapies such as stem cell transplant and stem cell therapy could
potentially improve medical outcomes of chronic diseases. Also, pure
stem cells are required to conduct research for various purposes.
Stem cell transplant could replace the neurons damaged by spinal cord
injury, stroke, and Alzheimer’s disease. These factors are expected
to drive growth of the stem cell assay market over the forecast
period. Moreover, organizations such as California’s Stem Cell
Agency is indulged in the development of new stem cell based
therapies for chronic diseases such as cancer and rare diseases.
Stem
Cell Assay Market Insights
North
America and Europe are expected to witness significant growth in the
market over the forecast period. This is owing to presence of key
manufacturers and researchers of stem cell based therapies in these
regions. Moreover, manufacturers such as ThermoFisher Scientific, and
Agilent Technologies, Inc. providing stem cell assay are present in
North America region, which fuel growth of the market. Asia Pacific
region is expected to show significant growth over the forecast
period, as researchers from China and Japan are working on stem cell
based therapies. For instance, in 2017, clinical trials of embryonic
stem cells were launched in China for Parkinson’s disease.
Stem
Cell Assay Market Competitive Landscape
Key
players operating in the global stem cell assay market include Merck
& Co., Thermo Fisher Scientific, GE Healthcare, Agilent
Technologies, Bio-Rad Laboratories, Promega Corporation, Cell
Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne
Corporation, STEMCELL Technologies, and Cellular Dynamics
International.
Stem
Cell Assay Market Taxonomy-
The
global stem cell assay market is segmented on the basis of product
type, cell type, process, application, and geography.
By
Product Type-
-
Instruments
-
Reagents & Kits
By
Application -
-
Research
-
Drug Discovery & Development
-
Regenerative Medicine
Find
the comprehensive research report here with a single click:
https://www.coherentmarketinsights.com/ongoing-insight/stem-cell-assay-market-1632
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment